JPX · 2689.T
OLBA HEALTHCARE HOLDINGS, Inc.
¥1,920+¥9 (+0.47%)
OLBA HEALTHCARE HOLDINGS, Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.21% below the high.
Loading market information…
JPX · 7792.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Colan Totte.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 9.9% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Colan Totte.Co.,Ltd.’s forward annual dividend is ¥50 per share, paid annual. The forward yield is 3.48% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Colan Totte.Co.,Ltd.’s next earnings report is currently expected on Nov 6, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Colan Totte.Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Colan Totte Co., Ltd., established in Osaka, Japan, in 1997, operates as an international firm specializing in the development and global distribution of therapeutic devices under its proprietary Colantotte brand. The company's diverse product portfolio features an array of magnetic therapy items for domestic use, including specialized necklaces designed to alleviate neck and shoulder discomfort, loop-style products for arm support, various general joint supporters, performance-enhancing recovery apparel, and magnetic pillows. In addition to these physical goods, they also offer sleep-enhancing supplements. Furthermore, Colan Totte manages the Colantotte Safety System, an emergency notification service accessible via a unique card, pendant, or keychain. Their sales strategy incorporates wholesale partnerships, directly managed retail outlets, and a comprehensive online platform.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,920+¥9 (+0.47%)
OLBA HEALTHCARE HOLDINGS, Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.21% below the high.
¥559+¥29 (+5.47%)
Medical System Network Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 2.1% below the high.
¥4,975-¥10 (-0.2%)
Hoshi Iryo-Sanki Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.08% below the high.
¥578-¥9 (-1.53%)
Japan Medical Dynamic Marketing, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.49% below the high.
¥2,161+¥63 (+3.0%)
Techno Medica Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 22.46% below the high.
¥260+¥2 (+0.78%)
Taiko Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.98% below the high.
¥418+¥2 (+0.48%)
Daiken Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.52% below the high.
¥930¥0 (0.0%)
DVx Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.21% below the high.
